Back to company

UNIPHARMA ApS: Financial statements 2023

CVR: 78881917

UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -88 the year before. Equity amounted to DKK -124,033.

Gross Profit
0 kr.
Profit/Loss
0 kr.
Equity
-124,033 kr.
Total Assets
0 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-00-124 t.0
202200-8856 t.-
2021---5 t.57 t.-
2020-5 t.-5 t.-5 t.62 t.-
2019-5 t.-5 t.-5 t.67 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

UNIPHARMA ApS: The 2022 annual report is outJun 18, 2023

UNIPHARMA ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -88.

Ole Reumert joins UNIPHARMA ApS as directorMay 1, 2023

As of May 1, 2023, Ole Reumert is registered as director of UNIPHARMA ApS.

About UNIPHARMA ApS

UNIPHARMA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert and Ebba Dorrit Reumert. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK -124,033.